CDKN2A and chronic obstructive pulmonary disease: We quantified the mRNA expression of CDKIs (p21, p53, and p16) in peripheral blood mononuclear cells (PBMCs) of patients with COPD and observed a reduction of these markers after 6 mo of PA intervention (Fig. 2D).